Research to investigate new treatments for secondary progressive MS

New research funded by the Efficacy and Mechanism Evaluation (EME) Programme, an MRC and NIHR partnership, in collaboration with the MS Society will determine if new drug treatments could slow down the progression of disability in Secondary Progressive Multiple Sclerosis (SPMS).Multiple Sclerosis (MS) is a progressive disorder of the central nervous system,...
Source: NIHR Evaluation, Trials and Studies News - Category: American Health Source Type: news